Lymphoma in Dogs: Types, Chemotherapy Options and What to Expect
Lymphoma is one of the most frequently diagnosed cancers in dogs, representing around 7 to 24% of all canine cancer cases depending on the population studied. It is also one of the most treatable, with chemotherapy offering real periods of remission and maintained quality of life for many dogs. Understanding the different types and what treatment involves can help you navigate a diagnosis with more confidence.
What Is Canine Lymphoma?
Lymphoma is a cancer of the lymphocytes — white blood cells that form a key part of the immune system. Because lymphoid tissue is distributed throughout the body, lymphoma can arise in many locations. The disease encompasses a broad group of cancers that behave quite differently from one another, which is why accurate diagnosis and classification matters so much for treatment planning.
The Main Types of Lymphoma
Multicentric Lymphoma
This is by far the most common form, accounting for around 80 to 85% of canine lymphoma cases. It presents as enlargement of multiple peripheral lymph nodes — the lumps you can feel under the jaw, in front of the shoulders, in the armpits, and behind the knees. Dogs are often otherwise well when first diagnosed, which can make the swelling all the more alarming to discover. As the disease progresses, lethargy, weight loss, and reduced appetite typically follow.
Alimentary Lymphoma
This form affects the gastrointestinal tract and is the second most common type. Signs include vomiting, diarrhoea, weight loss, and reduced appetite. It is often more challenging to treat than multicentric lymphoma, and prognosis is generally more guarded.
Mediastinal Lymphoma
Mediastinal lymphoma involves lymphoid tissue in the chest, often including the thymus. It can cause respiratory distress, difficulty swallowing, and oedema of the face and forelimbs due to pressure on surrounding structures. This form is associated with hypercalcaemia — elevated blood calcium — in some cases.
Cutaneous Lymphoma
This rare form primarily affects the skin, presenting as scaling, redness, hair loss, and sometimes nodules. It is typically slower growing but can be difficult to manage long-term.
Diagnosing and Classifying Lymphoma
Fine needle aspiration of affected lymph nodes or tissue is often the first diagnostic step and can rapidly confirm lymphoma in many cases. However, biopsy with histopathology provides more detailed information about the tumour type and subtype.
Immunophenotyping — determining whether the tumour is B-cell or T-cell in origin — is critically important. B-cell lymphoma carries a significantly better prognosis than T-cell lymphoma, with higher remission rates and longer median survival times. Dogs with T-cell lymphoma tend to respond less durably to standard chemotherapy protocols.
Staging involves blood work, urinalysis, thoracic radiographs, and abdominal ultrasound to determine how widely the disease has spread.
Chemotherapy: The Mainstay of Treatment
Unlike many cancers where surgery is the primary treatment, lymphoma is generally treated with chemotherapy because it is a systemic disease involving the whole lymphoid system. Dogs tolerate chemotherapy considerably better than humans do — severe side effects are less common, and most dogs maintain a reasonable quality of life during treatment.
CHOP Protocol
The gold standard for multicentric B-cell lymphoma is the CHOP protocol, a combination chemotherapy regimen using cyclophosphamide, doxorubicin (hydroxydaunorubicin), vincristine (Oncovin), and prednisolone. Treatment is given over approximately 19 to 25 weeks, with visits to the oncology team typically weekly at first, then spacing out as the protocol progresses.
Remission rates with CHOP are around 80 to 90% for B-cell multicentric lymphoma, with a median first remission lasting approximately 12 months. Around 25% of dogs achieve a second remission and live beyond two years.
Single-Agent Protocols
For dogs where owner circumstances, finances, or the dog's overall health make multi-agent chemotherapy unsuitable, single-agent protocols using doxorubicin alone or lomustine can provide meaningful periods of remission, though typically shorter than with CHOP.
Prednisolone Alone
When chemotherapy is not pursued, prednisolone (a corticosteroid) can provide temporary improvement in wellbeing and modest tumour reduction. It is important to know that prior prednisolone treatment can induce multi-drug resistance, potentially reducing the effectiveness of chemotherapy if it is started later. This is a significant consideration worth discussing with your vet before making decisions.
Managing Side Effects
The most common side effects of CHOP chemotherapy in dogs are gastrointestinal — vomiting, diarrhoea, and reduced appetite — and these typically occur three to five days after treatment. Myelosuppression (a drop in white blood cell counts) is also monitored through regular blood tests, usually taken before each treatment cycle.
Doxorubicin carries a cumulative cardiac risk at higher doses, so total dose is monitored carefully. Your oncology team will provide anti-nausea medications and clear guidance on what signs to watch for at home.
Most dogs continue to enjoy walks, food, and family interaction throughout treatment. The aim is always remission with quality of life preserved, not simply extension of life at any cost.
What Does Remission Actually Mean?
Remission means that the signs of lymphoma are no longer detectable — lymph nodes return to normal size, and the dog feels well. It does not mean cure. Lymphoma almost always returns, at which point rescue chemotherapy protocols can be attempted, though response rates and remission lengths are typically shorter second time around.
Understanding this from the outset helps set realistic expectations. Many families describe the remission period as genuinely good time — their dog happy, active, and engaged. Making the most of that time is at the heart of the decision to pursue treatment.
Questions Worth Asking Your Oncologist
- Is this B-cell or T-cell lymphoma, and how does that change the outlook?
- What stage is the disease at diagnosis?
- What is the realistic remission expectation for my dog specifically?
- How will we monitor for side effects, and when should I call the clinic?
- What does a typical week look like during treatment?
Canine lymphoma is not a diagnosis to face alone. Veterinary oncology teams are experienced in supporting both dogs and their families through this process, and the conversations you have early on will shape the path you take together.